Valuation: ALTEOGEN Inc.

Market Cap 18,827B 12.22B 10.68B 9.8B 9.14B 17.33B 1,163B 17.63B 118B 45.75B 571B 45.88B 44.89B 1,966B P/E 2026 *
64.3x
P/E 2027 * 43.1x
Enterprise Value 18.33B 11.9M 10.39M 9.55M 8.9M 16.88M 1.13B 17.16M 115M 44.54M 555M 44.67M 43.7M 1.91B EV / Sales 2026 *
39.1x
EV / Sales 2027 * 26.8x
Free-Float
74.26%
Yield 2026 *
0.15%
Yield 2027 * 0.15%
1 day-1.82%
1 week-6.27%
Current month-2.63%
1 month-1.54%
3 months-0.14%
6 months-23.09%
Current year-21.80%
1 week 349,000
Extreme 349000
385,500
1 month 286,000
Extreme 286000
397,500
Current year 286,000
Extreme 286000
529,000
1 year 286,000
Extreme 286000
569,000
3 years 38,000
Extreme 38000
569,000
5 years 27,875
Extreme 27875
569,000
10 years 3,645.83
Extreme 3645.8333
569,000
Manager TitleAgeSince
Chief Executive Officer 60 2025-12-25
Director of Finance/CFO 61 2023-03-27
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 2008-05-12
Director/Board Member 70 2021-03-28
Director/Board Member 61 2023-03-27
Date Insider Type Main position Quantity % Market Cap.
25-05-20Fiscal year

Chief Executive Officer

7,200 0.0135%
24-03-26Sell 1,600,000 3.0182%
24-01-04Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
-1.82%-6.27%-10.45%+718.39% 12.22B
+4.73%+5.50%+19.45%-8.94% 66.56B
-2.27%+0.04%+58.07%+225.20% 57.64B
+0.72%+40.60%+40.60%+40.60% 42.24B
+3.45%+6.04%-49.46%-55.91% 39.09B
-4.05%+7.01%+62.26%-24.13% 31.91B
-1.99%+33.49%+163.41%-34.35% 31.65B
-0.28%+8.68%+71.42%+87.73% 23.35B
+2.87%+16.83%+3.78%+192.67% 18.92B
-0.10%+2.87%+67.69%+130.36% 17.17B
Average +2.33%+7.54%+42.68%+127.16% 34.08B
Weighted average by Cap. +2.51%+7.16%+42.13%+78.56%

Financials

2026 *2027 *
Net sales 469B 304M 266M 244M 228M 432M 28.96B 439M 2.94B 1.14B 14.21B 1.14B 1.12B 48.95B 672B 436M 381M 350M 326M 619M 41.53B 629M 4.21B 1.63B 20.37B 1.64B 1.6B 70.19B
Net income 311B 202M 176M 162M 151M 286M 19.2B 291M 1.95B 755M 9.42B 757M 741M 32.44B 397B 257M 225M 207M 193M 365M 24.5B 371M 2.49B 964M 12.02B 966M 945M 41.41B
Net Debt -499B -324M -283M -260M -242M -459M -30.82B -467M -3.13B -1.21B -15.12B -1.22B -1.19B -52.09B -828B -537M -469M -431M -402M -762M -51.14B -775M -5.19B -2.01B -25.08B -2.02B -1.97B -86.43B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
172
Date Price Change Volume
26-07-02 ₩351,500.00 -1.82% 392,958
26-07-01 ₩358,000.00 -0.83% 439,869
26-06-30 ₩361,000.00 -3.22% 432,302
26-06-29 ₩373,000.00 +8.59% 686,307
26-06-26 ₩343,500.00 -8.40% 564,203
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
351,500.00KRW
Average target price
458,000.00KRW
Spread / Average Target
+30.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock